Chris Cuvelier
2021
In 2021, Chris Cuvelier earned a total compensation of $535.7K as Chief Growth Officer at Arcadia Biosciences.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Non-Equity Incentive Plan | $9,479 |
| Option Awards | $227,454 |
| Salary | $152,889 |
| Other | $20,833 |
| Total | $535,655 |
Cuvelier received $227.5K in option awards, accounting for 42% of the total pay in 2021.
Cuvelier also received $125K in bonus, $9.5K in non-equity incentive plan, $152.9K in salary and $20.8K in other compensation.
Rankings
In 2021, Chris Cuvelier's compensation ranked 10,570th out of 12,405 executives tracked by ExecPay. In other words, Cuvelier earned more than 14.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,570 out of 12,405 | 15th |
Division Agriculture, Forestry, And Fishing | 46 out of 66 | 30th |
Major group Agricultural Production Crops | 34 out of 45 | 24th |
Source: SEC filing on April 19, 2022.
Cuvelier's colleagues
We found three more compensation records of executives who worked with Chris Cuvelier at Arcadia Biosciences in 2021.